Section on Implementing Evidence-Based Interventions for Sickle Cell Disease (ISCD)

Sickle Cell Disease (SCD), an inherited blood disease characterized by anemia, severe pain and other vasoocclusive complications, and early mortality, is endemic to populations residing in sub-Saharan Africa, yet evidence-based interventions are rarely available, accessible, or widely adopted for disease management.

The mission of the ISCD Section is to understand the who, why, where, and how interventions for SCD management are adopted by certain communities and not others, and ultimately implement sustainable and scalable evidence-based interventions in a context appropriate manner. Because context matters, approaching interventions with cultural sensitivity and innovation for diverse populations in low resource settings, and continuous engagement of key stakeholders is key to improving health and overall health outcomes.

Section Leader: Joyce Gyamfi, EdD, MS (gyamfj01@nyu.edu)